A proof-of-concept diagnostic tool capable of identifying bladder cancer through RNA fragments present in urine has demonstrated potential in recent research. The test analyzes genetic material shed into urine, offering a non-invasive alternative to traditional cystoscopy for detecting the disease. Researchers indicate this method could significantly streamline the diagnostic process, potentially enabling earlier intervention and improved patient monitoring.
